SUBSCRIBE
SUBSCRIBE
News   Business

Biodel Inc. Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update

February 6, 2009 | 
1 min read
DANBURY, Conn.--(BUSINESS WIRE)--Biodel Inc. (Nasdaq: BIOD) today reported financial results for the first quarter ended December 31, 2008 and provided an update on recent clinical findings with its lead product candidate, VIAject™.
Earnings
MORE ON THIS TOPIC
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
3D illustration of hair root growing from skin cells, symbolizing strength, growth, and nourishment. Perfect for haircare, cosmetic advertising, medical research, and healthcare concepts.
Funding
Veradermics Gets $150M Series C To Advance Hair Regrowth Pill
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac